CuraScientific Corp

OTC: CSTF · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Coachella, OKCIK 0001877788Reports USD

#1085 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ 13GM —SS 39

v0.1 · 25/100 weight · pillars only

↑ Altman-Z, listing tenure · ↓ workforce scale, balance-sheet leverage

Methodology →

Revenue TTM

$671.7k

Rev growth YoY (TTM)

+954.6%

Net income (FY)

-$5.3M

Employees

Market cap

$377.3k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$34.4k$34.4k2022

Net income-$5.3M-$5.3M2022

Operating income-$2.4M-$2.4M2022

Total assets$1.6M$1.6M2022

Liabilities$71.1M$71.1M2022

Equity-$69.5M-$69.5M2022

Revenue trend

FY2021 – FY2022 · USD

$60.2k

FY21

$86.3k

FY21

$34.4k

FY22

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

CuraScientific Corp booked $34.4k in FY2022 revenue, contracting 60% year over year — slower than 85% of Healthcare companies we track, at a -15299.2% net margin.

Peers · Healthcare

ProPhase Labs, Inc.38D Biocure Technology Inc.——Longevity Health Holdings Inc.22D ViaDerma, Inc.——

Key facts

CEOSamuel L. Berry

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersCoachella, OK

ExchangeOTC: CSTF

Employees2

IPO date1998-01-08

Latest filings

8-K2024-02-09 8-K2024-01-10 8-K2024-01-02 8-K2023-12-11 10-Q2023-12-08 10-Q2023-08-21 8-K2023-05-30 8-K2023-05-30

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.